• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 1012014-150
Device Problems Entrapment of Device (1212); Device Damaged by Another Device (2915); Mechanical Jam (2983); Activation Failure (3270)
Patient Problems Unspecified Tissue Injury (4559); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/15/2022
Event Type  Injury  
Manufacturer Narrative
The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.On may 11th, 2022, abbott determined that a field safety notice was required for the absolute pro ll peripheral self-expanding stent system (psess).Abbott has confirmed reports of mechanical locking, stent deployment and partial stent deployment failures, resulting from unintended excessive force used to deploy the stent.To reduce occurrences of deployment failures and associated outcomes, abbott is notifying all users of the potential causes and risks.
 
Event Description
It was reported that the procedure was to treat the popliteal artery.The patient has a history of chronic occlusion of the superficial femoral artery.The 5x150 mm absolute pro self expanding stent system (sess) was advanced to the lesion and deployment was attempted.After one centimeter had been deployed, deployment was blocked as the deployment mechanism would not operate.The sess could also not be withdrawn so transversion was performed to remove the stent and sess.During removal of the stent and delivery system, a previously implanted stent was displaced and additional surgery was performed to remove the stent.The target lesion was treated with two additional stents.Another procedure was performed on (b)(6) 2022 due to a groin hematoma and the patient remained hospitalized.The groin hematoma was probably due to the removal of the cross sheath which caused trauma to the artery.The hematoma was treated with incision and draining on (b)(6) 2022.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported mechanical jam and the reported activation failure were unable to be replicated in a testing environment due to the condition of the returned device.The reported entrapment of device and the reported device damaged by another device were unable to be replicated in a testing environment as it was based on operational circumstances.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.It is possible that interaction with the anatomy/other devices and/or inadvertent mishandling resulted in the noted device damages (bunched distal sheath, kinked/cracked outer member jacket, multiple smashed strain relief) thus preventing the shaft lumens from moving freely and thus resulting in the reported mechanical jam and the reported activation/deployment failure; however this cannot be confirmed.The investigation determined a conclusive cause for the reported mechanical jam and the reported activation/deployment failure cannot be determined.The noted device damages (torn/twisted ribbon, separated inner member, stretched/flared/deformed stent) likely occurred due to inadvertent mishandling during/post procedure or during packing for return analysis.The treatment appears to be related to the operational context of the procedure as during removal of the stent and delivery system a previously implanted stent was displaced resulting in the reported entrapment of device, the reported device damaged by another and additional surgery was performed to remove the stent.There is no indication of a product quality issue with respect to manufacture, design or labeling.On may 11th, 2022, abbott determined that a field safety notice was required for the absolute pro ll peripheral self-expanding stent system (psess).Abbott has confirmed reports of mechanical locking, stent deployment and partial stent deployment failures, resulting from unintended excessive force used to deploy the stent.To reduce occurrences of deployment failures and associated outcomes, abbott is notifying all users of the potential causes and risks.H6: health effect clinical code 4582 removed; 4559 added.Health effect impact code 4641 removed; 4624 added.Medical device problem code 2915 added.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key15065397
MDR Text Key296228808
Report Number2024168-2022-07927
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodePL
PMA/PMN Number
P110028
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Notification
Type of Report Initial,Followup
Report Date 09/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/20/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1012014-150
Device Lot Number1112261
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/01/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/22/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
HT COMMAND 18
Patient Outcome(s) Required Intervention;
Patient Age87 YR
Patient SexFemale
Patient Weight70 KG
Patient RaceWhite
-
-